Improved Ziprasidone Formulations with Enhanced Bioavailability in the Fasted State and a Reduced Food Effect

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: A randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder

(2010) Jeffrey J. Miceli et al.   CLINICAL THERAPEUTICS

Strategies for successful clinical management of schizophrenia with ziprasidone

(2010) Andrea Fagiolini et al.   EXPERT OPINION ON PHARMACOTHERAPY

How Sequential Studies Inform Drug Development: Evaluating the Effect of Food Intake on Optimal Bioavailability of Ziprasidone

(2010) Jana Lincoln et al.   Journal of Psychiatric Practice

Using oral ziprasidone effectively: the food effect and dose-response

(2009) Leslie Citrome   ADVANCES IN THERAPY

The Impact of Calories and Fat Content of Meals on Oral Ziprasidone Absorption

(2009) Kuan Gandelman et al.   JOURNAL OF CLINICAL PSYCHIATRY

How Dosing of Ziprasidone in a State Hospital System Differs From Product Labeling

(2009) Leslie Citrome et al.   JOURNAL OF CLINICAL PSYCHIATRY

Hydroxypropyl Methylcellulose Acetate Succinate-Based Spray-Dried Dispersions: An Overview

(2008) Dwayne T. Friesen et al.   MOLECULAR PHARMACEUTICS

Enhancing intestinal drug solubilisation using lipid-based delivery systems

(2007) Christopher J.H. Porter et al.   ADVANCED DRUG DELIVERY REVIEWS